Loading...
Loading...
Haemonetics Corporation
HAE shares fell 5.7% to $31.43. Raymond James downgraded Haemonetics from market perform to underperform. Share volume was 36,000, compared to an all-day average of 86,000
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in